Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Come one...8k aside ...we all know he was a member of the BOD. Just another sloppy miss for SVFC maybe, but he is on it. Too many press releases.
117 million
No, I'm asking when was the last time someone checked. Was that the date YOU checked? Has anyone asked since then? Has anyone ventured a "why" to him? Seems like a pretty reasonable question.
I'm not interested in old data.
When was the last time anyone spoke with Dr Andrews to see how often he used the cavitation technique?
This was exactly my experience of him. Good post!
I think what you're hoping for is what is coming. Good news, bad news, Hanover's position is that shareholder's deserve a steady stream of truth. If after a day of fact finding on Friday they can agree to a model, that's what should happen. We might not all like what we hear initially, but I think we would all agree that ongoing communication from Intellicell-good or bad- is better than our having to continue to read tea leaves.
As for me, I'm very pleased they are taking this step.
I was told the same thing and more information would be available Friday. Moreover, they called me back.
Things change.
Huh? Be more specific. Give the company/name that YOU think is correct so that we can be better informed.
ANd.... since we've been sent to Jim Hock... here's his LinkedIN cred
https://www.linkedin.com/pub/james-hock/a/a2/1a0
I note he lists both regen AND Intellicell. How does this bode for Intellicell getting the new CEO it needs and does this doom regen?
2006....lots of people learn and grow and become something more complicated in 8 years. The suggestion that this woman could not is beneath us and denigrating to her.
I was told that Hanover had taken over the media awareness and that "Kathy" was the new contact. Ka@hanoverintlinc.com.
Good luck.
We are all "guessing " why he doesn't update anyone now.
Love the carefulness and thought behind your analyses. Thank you.
Old ...not criminal AND ...was brought under under compliance. Please stop. Zzzzzz
This is old data and no longer germane
That is beside the point. They could have been done poorly. They weren't. They were thoroughly done...for a reason.
Logic dictates that victor and everyone else involved is more interested in a bigger , long term payday. Otherwise...no reason to revise financials and to keep up w them w such accuracy. There are bigger things coming.
Logic sometimes must face fallacy. What is apparent does not aways support what is true. Time will tell the truth.
I think you should enjoy it! Now, when the ship turns, enjoy profits of the other sort.
He is more interested in a much larger payday than the posting suggests. The technology is sufficient so no we just need to be patient. It's easy to paint the past. Harder to predict to future - but the data suggests that this is a good place for longs to work on their patience.
In the end, everyone gets greedy. The market depends on this. Greed v fear. In this case, the data suggests that some good this way comes. I'm not afraid.
Thanks for the reminder that we are playing the right penny stock!
This suggests that Dr Victor et al have no interest in growing the company to be more productive AND profitable. That just makes no sense at all. In fact, using the reasoning in previous posts, it makes more sense that they would work to make great gobs of $$$, versus the tiny sums we are talking about now. The potential for SVFC is huge... Especially for Dr Vic and Anna.
In SHORT, I think the post's reasoning is flawed and it's more likely that Vic is interested in a bigger long term pay day. Just my opinion.
Wow...did you personally verify each statement made in this post?
http://hanoverinternationalinc.com/
SVFC 's new marketing/market awareness firm.
Good news, yes?
I was thinking out loud...since I've already made the effort to go the the Intellicell office, I was making a @&)#*%/:; point. Just as I did before, I will start trying to make contact w board members to get more info- even though that may prove fruitless.
Someone..,place a call to Andrews and/or Hill.
Does someone have a list of the current BOD?
And.... Always good reading:
http://www.google.com/patents/US8440440
Migraine and Tension-Type Headache Treated With Stromal Vascular Fraction: A Case Series
Ralph Bright, Matthew Bright, Pelin Bright, Shannon Hayne, Wayne D ThomasDisclosures
J Med Case Reports. 2014;8(237)
ABSTRACT AND INTRODUCTION
Abstract
Introduction: Chronic migraines and tension-type headaches are debilitating diseases affecting 1.4 to 2.2% of the population with both quality of life and economic implications. To date, the pain associated with migraine and tension-type headaches has been controlled with a range of medications, with varying levels of success. In addition, the side-effect profile of these medications, as well as their potential for addiction, has been a cause for concern for both patients and physicians.
Case presentations: Four women with long histories of migraine or frequent tension-type headache that meet the International Classification of Headache Disorders criteria for Chronic Migraine or Tension-type Headaches were given a systemic treatment(s) of autologous stromal vascular fraction or autologous 'StroMed' isolated from lipoaspirate. StroMed is stromal vascular fraction cells prepared by ultrasonic cavitation. Two of the four patients, both of whom are Arab women aged 40 and 36 years, ceased having migraines after 1 month, for a period of 12 to 18 months. The third patient, a Slavic woman aged 43 years, had a significant decrease in the frequency and severity of migraines with only seven migraines over 18 months. The fourth patient, an Asian woman aged 44 years, obtained a temporary decrease for a period of a month and was retreated 18 months later and has been free of migraines to date for 1 month. Pain medication was typically reduced from prescribed opioid analgesia to non-steroidal anti-inflammatory drugs and paracetamol.
Conclusions: This case series is the first to provide evidence of the efficacy of autologous StroMed and stromal vascular fraction in the treatment of migraine and tension-type headache. The treatment of this disease by stromal vascular fraction adds a new dimension to its clinical applicability and suggests a relatively simple treatment that may help address the symptoms of the disease. Given what is known about the components of the stromal vascular fraction and how they act, the information presented in this case series may also further our knowledge of the etiology and pathophysiology of migraine and tension-type headaches. This treatment is simple, looks to be extremely effective and has been life changing for these patients.
If he uses the cavitation method...sure.
Has anyone gone to the Intellicell offices in the last month as recently suggested? It's a great idea.
It's time, with the current world wide press occurring, for SVFC's media campaign imo. I'm presuming Vic is there...but he is very hard to find...can anyone find him..,anywhere?
Quote:
Adipose tissue until recently was considered to be poor grafting material in tissue reconstruction. Pioneering work by Sidney Coleman MD on processing techniques for fat grafting led to its increased use. As adipose tissue grafting became widespread its regenerative properties came to the fore as surgeons noticed unexpected skin rejuvenation, scar resolution, and most remarkably reversal of hitherto intractable conditions such as radiation fibrosis. In the late ’90s under the direction of William Futrell MD at the University of Pittsburgh, Adam Katz MD first isolated and recognized the abundant presence of MSC’s (mesenchymal stem cells) in adipose tissue, thus providing the key to understanding the regenerative potential of Adipose tissue which is contained in its Stromal Vascular Fraction (SVF). Building on this foundation, Peter Rubin MD has created a powerhouse engine of academic research and the central nexus for Adipose tissue and SVF science at the University of Pittsburgh. Bringing SVF technologies to market is a arduous process but William Cimino PhD, CEO of GID *******has proven autologous SVF therapy is not only market ready, but already being deployed in several countries successfully.*******
SVFC is up soon....count on it.
Excellent short term analysis. Now, back to praying that a new CEO (Ray Hill) is announced. Okay...or someone like that.
Uh...how are you picking up 1's? Old order?
Thank you, I'd rather not guess. I'd like to "know."
Who wrote the entire header information for SVFC on the IHUB page?
Anyone having worked with a patenting process for a biological process will find what SVFC is doing familiar.
It's not a magical reworking of words.
Sigh...
Hahahahaha ha....
Okay, why? With all the billions of shares ...why?
I would be thrilled with a dollar a share...but I don't think we can do that unless the current new financier is holder most of the float as a form of buy back, thus avoiding an RS *W A Y down the road.*